A low molecular weight brain substance interacts, similarly to clonidine, with α2-adrenoceptors of human platelets
- 1 December 1987
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 144 (3) , 247-255
- https://doi.org/10.1016/0014-2999(87)90377-3
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medullaEuropean Journal of Pharmacology, 1987
- An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferensBiochemical and Biophysical Research Communications, 1986
- β-adrenergic activity and conformation of the antihypertensive specific α2-agonist drug, guanabenzBiochemical Pharmacology, 1985
- Isolation and partial purification of a clonidine‐displacing endogenous brain substanceEuropean Journal of Biochemistry, 1984
- Effects of α2‐adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human plateletsBritish Journal of Pharmacology, 1984
- Isolation of an endogenous clonidine‐displacing substance from rat brainFEBS Letters, 1984
- Alpha-adrenergic drugs: Pharmacological tools for the study of the central vasomotor controlBiochemical Pharmacology, 1983
- Interrelationships between clonidine and histaminergic mechanismsTrends in Pharmacological Sciences, 1981
- Inhibition of hamster fat cell adenylate cyclase by prostaglandin E1 and epinephrine: Requirement for GTP and sodium ionsFEBS Letters, 1979
- Novel α2-adrenoreceptors primarily responsible for inducing human platelet aggregationNature, 1979